Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2014; 20(13): 3597-3608
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3597
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3597
Table 2 Primary antibodies used in this study
Primary antibody | Source | Clone | Animal | Type | Pretreatment | Dilution |
CD3 | Nichirei | PS1 | Mouse | Mono | MW3 | 1:1 |
CD4 | Nichirei | 4B12 | Mouse | Mono | MW3 | 1:1 |
CD8 | Dako | C8/144B | Mouse | Mono | MW1 | 1:20 |
CD20 | Dako | L26 | Mouse | Mono | - | 1:400 |
CD38 | Epitomics | EPR4106 | Rabbit | Mono | AC2 | 1:800 |
CD138 | Dako | ML15 | Mouse | Mono | MW3 | 1:100 |
IgG | Dako | A57H | Mouse | Mono | - | 1:200 |
IgM | Nichirei | R1/69 | Mouse | Mono | MW3 | 1:1 |
IgA | Novocastra | N1CLA | Mouse | Mono | PK | 1:300 |
- Citation: Kobayashi M, Kakuda Y, Harada K, Sato Y, Sasaki M, Ikeda H, Terada M, Mukai M, Kaneko S, Nakanuma Y. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis. World J Gastroenterol 2014; 20(13): 3597-3608
- URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3597.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i13.3597